Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Selley

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Neurochemistry|May 22, 2001
Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activationD E Selley, W K Rorrer, C S Breivogel, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2021
Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures: In Vitro and In Vivo Studies with Opioids and CannabinoidsD E Selley, M L Banks, C M Diester, et al.
British Journal of Pharmacology|June 19, 2007
Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine toleranceL J Sim-Selley, K L Scoggins, M P Cassidy, et al.
Psychopharmacology|June 13, 2020
Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathyJulie A Meade, Y Alkhlaif, K M Contreras, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Synapse (New York, N.Y.)|February 23, 2008
Distinct patterns of DeltaFosB induction in brain by drugs of abuseL I Perrotti, R R Weaver, B Robison, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Neurochemistry|May 22, 2001
Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activationD E Selley, W K Rorrer, C S Breivogel, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2021
Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures: In Vitro and In Vivo Studies with Opioids and CannabinoidsD E Selley, M L Banks, C M Diester, et al.
British Journal of Pharmacology|June 19, 2007
Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine toleranceL J Sim-Selley, K L Scoggins, M P Cassidy, et al.
Psychopharmacology|June 13, 2020
Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathyJulie A Meade, Y Alkhlaif, K M Contreras, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Synapse (New York, N.Y.)|February 23, 2008
Distinct patterns of DeltaFosB induction in brain by drugs of abuseL I Perrotti, R R Weaver, B Robison, et al.
Pageof 4